Posted by
Intranasal esketamine combo tied to symptom improvement

Intranasal esketamine combo tied to symptom improvement

Concern raised about drug’s abuse potential Publish date: May 21, 2019 By Jim Kling REPORTING FROM APA 2019 SAN FRANCISCO – In treatment-resistant depression, a switch to a new antidepressant combined with inhaled esketamine (Spravato) led to better symptom improvement than did a switch to a new antidepressant plus placebo, results from a new trial show. The […]